The prevalence and genotype distribution of human papillomaviruses among women in Taizhou, China
- PMID: 31574850
- PMCID: PMC6775393
- DOI: 10.1097/MD.0000000000017293
The prevalence and genotype distribution of human papillomaviruses among women in Taizhou, China
Abstract
Human papillomavirus (HPV) infection is the leading cause of cervical cancer and precancerous lesions. Knowledge regarding the prevalence and genotype distribution of HPV in women is important to establish strategies for cervical cancer screening and HPV vaccination. This study aimed to evaluate the characteristics of HPV infection in Taizhou, China. HPV genotype of 10,733 women who visited Taizhou People's Hospital from November 2016 to October 2018 was determined using a PCR and hybridization-based detection test. The prevalence of overall, high risk (HR), and low risk (LR) HPV infections was 34.58%, 29.92%, and 10.12%, respectively. Of HPV-positive cases, 2417 (65.13%) were infected with a single HPV genotype and 1294 (34.87%) were infected with multiple HPV genotypes. HPV-52 was the most prevalent genotype (6.21%), followed by HPV-16 (5.33%), HPV-53 (4.03%), HPV-58 (3.89%), and HPV-81 (3.75%). The highest prevalence of HPV infection was found in women aged ≥60 years (40.72%). Furthermore, the prevalence of HPV increased with the severity of cervical lesions. In conclusions, the prevalence and genotype distribution of HPV varied with age and cervical lesions. The findings might serve as a potential reference for guiding cervical cancer screening and vaccine-based HPV prevention in Taizhou.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37 967 women from the general population.BMJ Open. 2017 Jun 9;7(6):e014135. doi: 10.1136/bmjopen-2016-014135. BMJ Open. 2017. PMID: 28601819 Free PMC article.
-
A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine.Cancer Epidemiol. 2023 Jun;84:102372. doi: 10.1016/j.canep.2023.102372. Epub 2023 Apr 27. Cancer Epidemiol. 2023. PMID: 37119603
-
Influence of COVID-19 pandemic on prevalence and genotype distribution of HPV in cervical cancer screening population.Virol J. 2024 Oct 23;21(1):261. doi: 10.1186/s12985-024-02497-6. Virol J. 2024. PMID: 39443958 Free PMC article.
-
Prevalence and genotype distribution of human papillomavirus infection among female outpatients in Northeast China: a population-based survey of 110,927 women.Arch Gynecol Obstet. 2023 Jul;308(1):35-41. doi: 10.1007/s00404-022-06653-7. Epub 2022 Jul 29. Arch Gynecol Obstet. 2023. PMID: 35904609 Review.
-
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.Vaccine. 2013 Dec 31;31 Suppl 7:H59-70. doi: 10.1016/j.vaccine.2013.03.029. Vaccine. 2013. PMID: 24332298 Review.
Cited by
-
Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia.Cancers (Basel). 2021 May 30;13(11):2691. doi: 10.3390/cancers13112691. Cancers (Basel). 2021. PMID: 34070706 Free PMC article. Review.
-
A Prospective, Non-interventional Observational Study to Assess the Efficacy, Safety, and Tolerability of the Casein Hydrolysate-Based Food Supplement in High-Risk Human Papillomavirus-Positive Women.Cureus. 2025 Mar 7;17(3):e80201. doi: 10.7759/cureus.80201. eCollection 2025 Mar. Cureus. 2025. PMID: 40061851 Free PMC article.
-
Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review.Hum Vaccin Immunother. 2024 Dec 31;20(1):2343192. doi: 10.1080/21645515.2024.2343192. Epub 2024 May 14. Hum Vaccin Immunother. 2024. PMID: 38745409 Free PMC article.
-
Absolute Risk and Attributable Fraction of Type-Specific Human Papillomavirus in Cervical Cancer and Precancerous Lesions-A Population-Based Study of 6286 Women in Rural Areas of China.J Clin Med. 2022 Oct 31;11(21):6483. doi: 10.3390/jcm11216483. J Clin Med. 2022. PMID: 36362711 Free PMC article.
-
Quality of life and its related-influencing factors in patients with cervical cancer based on the scale QLICP-CE(V2.0).BMC Womens Health. 2024 May 7;24(1):277. doi: 10.1186/s12905-024-03068-1. BMC Womens Health. 2024. PMID: 38714996 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424. - PubMed
-
- Zheng RS, Sun KX, Zhang SW, et al. [Report of cancer epidemiology in China, 2015]. Zhonghua Zhong Liu Za Zhi 2019;41:19–28. - PubMed
-
- de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13:607–15. - PubMed
-
- Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012;30suppl:F12–23. - PubMed